Alliancebernstein L.P. Novartis Ag Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Novartis Ag stock. As of the latest transaction made, Alliancebernstein L.P. holds 34,974 shares of NVS stock, worth $3.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,974

Previous 22,607 54.7%

Holding current value

$3.44 Million

Previous $2.41 Million 67.17%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$106.13 - $120.89 $1.31 Million - $1.5 Million	12,367 Added 54.7%	34,974 $4.02 Million
Q2 2024 Aug 14, 2024	SELL	$92.57 - $107.37 $2.79 Million - $3.24 Million	-30,176 Reduced 57.17%	22,607 $2.41 Million
Q1 2024 May 14, 2024	SELL	$95.27 - $108.47 $699,948 - $796,929	-7,347 Reduced 12.22%	52,783 $5.11 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $710,755 - $782,162	7,703 Added 14.69%	60,130 $6.07 Million
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $1.92 Million - $2.13 Million	20,220 Added 62.78%	52,427 $5.34 Million
Q2 2023 Aug 15, 2023	BUY	$92.52 - $104.91 $585,466 - $663,870	6,328 Added 24.45%	32,207 $3.25 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $69,546 - $80,651	-869 Reduced 3.25%	25,879 $2.38 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $13,674 - $16,746	181 Added 0.68%	26,748 $2.43 Million
Q3 2022 Nov 15, 2022	BUY	$74.61 - $87.26 $41,333 - $48,342	554 Added 2.13%	26,567 $2.02 Million
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $169,414 - $197,250	-2,104 Reduced 7.48%	26,013 $2.2 Million
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $64,088 - $72,496	-800 Reduced 2.77%	28,117 $2.47 Million
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $12,273 - $13,572	-154 Reduced 0.53%	28,917 $2.53 Million
Q3 2021 Nov 10, 2021	SELL	$81.78 - $95.14 $18,809 - $21,882	-230 Reduced 0.78%	29,071 $2.38 Million
Q2 2021 Jul 30, 2021	SELL	$85.24 - $94.15 $3.8 Million - $4.19 Million	-44,546 Reduced 60.32%	29,301 $2.67 Million
Q1 2021 May 06, 2021	BUY	$83.5 - $98.47 $3.49 Million - $4.12 Million	41,805 Added 130.47%	73,847 $6.31 Million
Q4 2020 Feb 08, 2021	BUY	$78.07 - $94.43 $67,842 - $82,059	869 Added 2.79%	32,042 $3.03 Million
Q3 2020 Nov 12, 2020	BUY	$82.14 - $91.0 $106,453 - $117,936	1,296 Added 4.34%	31,173 $2.71 Million
Q2 2020 Aug 13, 2020	BUY	$80.93 - $91.1 $84,005 - $94,561	1,038 Added 3.6%	29,877 $2.61 Million
Q1 2020 May 14, 2020	SELL	$70.67 - $99.01 $49,044 - $68,712	-694 Reduced 2.35%	28,839 $2.38 Million
Q4 2019 Feb 18, 2020	BUY	$84.35 - $95.37 $36,101 - $40,818	428 Added 1.47%	29,533 $2.8 Million
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $53,890 - $59,383	630 Added 2.21%	29,105 $2.53 Million
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $6.42 Million - $7.91 Million	-85,205 Reduced 74.95%	28,475 $2.6 Million
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $1.79 Million - $2.05 Million	23,747 Added 26.41%	113,680 $10.9 Million
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $5.62 Million - $6.26 Million	-76,324 Reduced 45.91%	89,933 $7.72 Million
Q3 2018 Nov 08, 2018	BUY	$66.94 - $77.43 $7.65 Million - $8.85 Million	114,318 Added 220.1%	166,257 $14.3 Million
Q2 2018 Aug 13, 2018	SELL	$64.91 - $73.36 $89,056 - $100,649	-1,372 Reduced 2.57%	51,939 $3.92 Million
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $81,652 - $97,614	-1,160 Reduced 2.13%	53,311 $4.31 Million
Q4 2017 Feb 13, 2018	SELL	$72.33 - $77.64 $1.26 Million - $1.35 Million	-17,449 Reduced 24.26%	54,471 $4.57 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $5.33 Million - $5.56 Million	71,920	71,920 $6.17 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Novartis Ag Transaction History